In combination with IDH status, IDH-wild-type and pTERT mutants are classified as GBM, IDH-mutants, and pTERT wild-type as astrocytoma, IDH-mutant, and pTERT mutants as oligodendrogliomas [83,100]. Here, IDH2 is linked to glioblastoma.